HON
57
3
PX
59
11
NRG
60
5
AMT
55
3
MSFT
46
2
FITB
53
-2
RL
65
5
EW
32
-2
NKE
21
3
TSCO
60
2
URI
42
2
PPL
82
-2
IVZ
35
2
XEL
64
2
A
40
-4
ROST
52
2
NEE
49
2
EOG
42
3
PBI
52
2
CMG
51
4
HON
57
3
PX
59
11
NRG
60
5
AMT
55
3
MSFT
46
2
FITB
53
-2
RL
65
5
EW
32
-2
NKE
21
3
TSCO
60
2
URI
42
2
PPL
82
-2
IVZ
35
2
XEL
64
2
A
40
-4
ROST
52
2
NEE
49
2
EOG
42
3
PBI
52
2
CMG
51
4
Financhill
Back

Bristol-Myers Squibb 10K Form

Sell
43

BMY
Bristol-Myers Squibb

Last Price:
$59.61
Seasonality Move:
3.14%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BMY News And Ratings

See the #1 stock for the next 7 days that we like better than BMY

BMY Financial Statistics

Sales & Book Value

Annual Sales: $48.3B
Cash Flow: $4.1B
Price / Cash Flow: 8.66
Annual Sales: $8.05
Price / Book: 7.4

Profitability

EPS (TTM): -4.42000
Net Income (TTM): $-8.9B
Gross Margin: $34.3B
Return on Equity: -46.27%
Return on Assets: -9.42%

Bristol-Myers Squibb Earnings Forecast

Key Bristol-Myers Squibb Financial Ratios

  • The Gross Profit Margin over the past 38 years for BMY is 71.08%.
  • The Selling, General & Administrative Expenses for BMY have been equal to 17.42% of Gross Profit Margin.
  • The Research & Development expenses have been 23.10% of Revenue.
  • The Net Earning history of BMY is -18.53% of Total Revenues.
  • Per Share Earnings over the last 38 years have been positive in 19 years.

Bristol-Myers Squibb Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: BMY
CUSIP: 110122
Website: bms.com

Debt

Debt-to-Equity Ratio: 3.04
Current Ratio: 1.25
Quick Ratio: 1.06

Price-to-Earnings

Trailing P/E Ratio: 14.88
Forward P/E Ratio: 9.68

BMY Technical Analysis vs Fundamental Analysis

Sell
43
Bristol-Myers Squibb (BMY) is a Sell

Is Bristol-Myers Squibb a Buy or a Sell?